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1. Introduction 
Mycotoxins are toxic fungal metabolites found as contaminants in many agricultural 
products. Feeds contaminated with mycotoxins have a health risk to animals and, as a 
consequence, may cause big economical losses due to the low efficacy of animal husbandry 
(Richard, 2007).  In addition, directly or indirectly (animal by-products) contaminated foods 
may also have a health risk to humans (CAST, 2003; Hussein & Brasel, 2001; Wild, 2007).  
Aflatoxins (AFs), a group of potent mycotoxins with mutagnic, carcinogenic, teratogenic, 
hepatotoxic and immunosupresive properties, are of particular importance because of their 
major occurrence and adverse effects on animal and human health, generalized as 
“aflatoxicosis” (CAST, 2003; Hussein & Brasel, 2001; Magnoli et al., 2011).  
The AFs are produced by genus Aspergillus, mainly A. flavus, A. parasiticus and A. nomius, 
that grow on a variety of raw material during growth, harvest, storage and transportation of 
for example, the cereal used in the preparation of food and feed commodities (Ito et al., 
2001; Kurtzman et al., 1987; Payne, 1998; Pereyra et al., 2010). 
The investigation of strategies to prevent the presence of AFs in foods, as well as, to 
eliminate, inactivate or reduce the bio-availability of these mycotoxins in contaminated 
products include physical, chemical, and biological methods (Bueno et al., 2001; CAST, 2003; 
Kabak et al., 2006). Limitations such as the loss of nutritional and sensory qualities of the 
product, the expensive equipment required for these techniques and the impossibility to 
guarantee the desired results, have allowed us to consider the hipothesis that foods and 
feeds can always be potentially contaminated with aflatoxins. For instance, in the poultry 
industry aflatoxin B1 (AFB1) is almost an unavoidable feed contaminant and levels from 0-
200 ng/g have been reported (Dalcero et al., 1997).  
On the other hand, it is known that lactic acid bacteria (LAB) and some yeast, principally 
Saccharomyces cerevisiae, are capable to bind AFs in liquid media, apparently to cell wall 
components, polysaccharides and peptidoglycans of LAB (Haskard et al., 2001; Latinen et 
al., 2004)  and glucomannans of yeast (Karaman et al., 2005; Raju & Devegowda, 2000) and 
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therefore  could be used as potential mycotoxin decontaminating (Armando et al., 2011; El-
Nezami et al., 1998; Haskard et al., 2000, 2001; Hernandez-Mendoza et al., 2009; Lee et al., 
2003; Peltonen et al., 2001; Shetty et al., 2007). The inclusion of appropriate microorganisms 
in the contaminated diet could prevent the absorption of mycotoxins during their passage in 
the gastrointestinal tract and eliminated in the faeces (Bueno et al., 2007; El-Nezami et al., 
2000; Gratz et al., 2004, 2007). Moreover, Kankaanpää et al. (2000) showed that the binding 
of AFB1 to the surface of LAB reduced their adhesive properties, and the accumulation of 
aflatoxins in the intestine may therefore be reduced via the increased excretion of an 
aflatoxin-bacteria complex.  
These considerations encouraged the recent emphasis on biological methods, but mainly 
focused on preventing AFs absorption in the gastrointestinal tract of the consumers, 
including these microorganisms in the diet and so prevent the aflatoxicosis effects.  
The first step in this direction is the selection of the most efficient microorganism for AFB1 
removing and while many researchers have assayed LAB and yeast with AFB1 binding 
abilities (Ciegler et al., 1966; El-Nezami et al., 1998; Gourama & Bullerman, 1995; Haskard et 
al., 2001; Line et al., 1994; Oatley et al., 2000) no clear mechanism for this effect has been 
provided. Thus, this selection frequently is performed using a single concentration of AFB1, 
but we demonstrated that the microorganism efficiency may change when the mycotoxin 
concentration is modified (Bueno et al., 2007; Pizzolitto, 2011), therefore the microorganism 
selected could not be the most competent.  
In this context, we investigated the nature of the interaction between different 
microorganisms and AFB1 molecule, which led us to develop a model to explain the 
binding of AFB1 by LAB and Saccharomyces cerevisiae strains. This model allows an 
estimation of two important parameters related to a microorganism's capacity for dietary 
decontamination: the number of binding sites for AFB1 in the surface microorganism (M) 
and the equilibrium constant of the process involved (Keq), both of them are useful in the 
selection of the most suitable microorganism in a wide range of AFB1 concentration 
(Bueno et al., 2007).  
In adittion, studies of viability of the microorganisms in the salivary and gastrointestinal 
tract, cell adhesion, autoaggregation, coaggregation and antimicrobial activity against 
pathogen strains, were also evaluated as a way to research potential beneficial properties on 
the host (Armando et al., 2011). 
Thus, in this chapter we describe the development and application of an in vitro 
methodology to evaluate the aflatoxin B1 binding ability, gastrointestinal tolerance and 
potential beneficial properties of Saccharomyces cerevisiae strains, useful to select the more 
appropriated microorganism to be assayed in expensive, complicated but necessary in vivo 
studies. 
2.1 Study of microorganism-aflatoxin B1 interaction 
To select accurately the most efficient microorganism to bind AFB1, is very important so as 
to protect against aflatoxicosis by inclusion of microorganisms in the diet. Usually, the 
methodology assayed has been a selection of several candidates using a unique mycotoxin 
concentration (Haskard et al., 2001; Hernandez-Mendoza et al., 2009; Peltonen et al., 2001; 
Shetty & Jespersen, 2006). Table 1, developed in our laboratory, is a clear example of this 
methodology and its analysis shows that the efficiency of the microorganisms is strain 
dependent, so that toxin removal ranged from 13 to 42% for LAB strains and 16 to 40% for 
the yeast strains tested.  
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Microorganism Source % AFB1 bound ± SDa 
Lactobacillus acidophilus Po22 Poultry cecum 42.8 ± 1.7 
L. acidophilus Po7 Poultry 34.6 ± 1.6 
L. acidophilus 24 Dairy 32.6 ± 2.0 
L. casei 1 Dairy 27.6 ± 1.5 
L. fermentum 23 Human 34.6 ± 3.2 
L. acidophilus CRL 1014 ATCC collectionb 25.4 ± 1.7 
L. fermentum subsp. cellobiosus 408 Poultry 13.2 ± 9.8 
Saccharomyces cerevisiae RC016 Pig gut 15.8 ± 3.6 
S. cerevisiae RC012 Feedstuff 29.6 ± 2.4 
S. cerevisiae RC008 Feedstuff 20.6 ± 2.6 
S. cerevisiae RC009 Feedstuff 16.4 ± 1.2 
S. cerevisiae 01 Poultry faeces 28.6 ± 3.5 
S. cerevisiae 03 Poultry faeces 26.6 ± 2.9 
S. cerevisiae 05 Poultry faeces 33.4 ± 1.9 
S. cerevisiae 08 Poultry faeces 36.4 ± 2.7 
S. cerevisiae CECT 1891 STCC collectionc 40.0 ± 2.5 
a The percentage of AFB1 bound to cells was calculated as the difference between the total AFB1 (5 µg ml-1) 
and the amount of free AFB1 (supernatant). Values are means ± standard deviations for duplicate samples. 
bATCC, American Type Culture Collection, Manassas, VA, USA. 
c STCC, Spanish Type Culture Collection, University of Valencia, Valencia, Spain. 
Table 1. Percentage of AFB1 bound to cells upon exposure to viable microorganisms 
Bacteria, 2 x 108 CFU ml-1 and yeast 1 x 107 CFU ml-1 were incubated with 1 ml of AFB1  
(5 µg ml-1) in PBS for 30 min at 37°C. The microorganisms were then pelleted by 
centrifugation, and the supernatant was collected for free AFB1 analysis by HPLC  
according to Bueno et al. (2007).  
The same experiment, but using three different concentrations of aflatoxin B1, shows that the 
microorganism assayed to one concentration could not be the most efficient when the latter is 
changed (Table 2 and 3). Thus when AFB1 concentration was 50 ng ml-1, S. cerevisiae RC 016 
was the most effective strain, but S. cerevisiae 08 and S. cerevisiae CECT 1891 were the best when 
AFB1 concentration was increased at 100 ng ml-1, and with 500 ng ml-1 of AFB1 S. cerevisiae RC 
016 was again the most efficient strain. In addition, S. cerevisiae 01 and S. cerevisiae 03 removed 
AFB1 with similar ability when their concentrations were 50 and 100 ng ml-1; however S. 
cerevisiae 01 was more effective at 500 ng ml-1 (Table 2). Lactic acid bacteria strains also showed 
the same behaviour, because L. rhamnosus I, L. acidophilus 24 and L. casei subsp. rhamnosus were 
the best at 50, 100 and 500 ng ml-1 respectively (Table 3).  
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Strains 
AFB1 concentration (ng ml-1) 
50 100 500 
AFB1 binding 
(ng ml-1) % (ng ml-1) % (ng ml-1) % 
S.  cerevisiae  CECT 1891 10.0 ± 4.3 20.0 57.6 ± 8.6 57.6 255.0 ± 32.1 51.0 
S. cerevisiae RC 008 33.8 ± 0.1 67.6 45.6 ± 7.1 45.6 197.9 ± 24.1 38.2 
S. cerevisiae RC 012 15.3 ± 1.6 29.6 21.5 ± 3.1 21.5 103.7 ± 9.4 20.2 
S. cerevisiae RC 009 8.4 ± 0.8 16.8 21.5 ± 0.8 21.5 159.3 ± 1.2 31.8 
S. cerevisiae RC 016 41.6 ± 1.9 82.0 49.1 ± 1.4 49.1 328.8 ± 5.2 65.7 
S. cerevisiae 01 19.3 ± 1.2 38.6 31.7 ± 1.2 31.7 164.0 ± 6.9 32.8 
S. cerevisiae 03 23.3 ± 2.9 46.6 34.5 ± 1.8 34.5 128.7 ± 5.8 25.7 
S. cerevisiae 05 16.7 ± 1.2 33.4 24.0 ± 1.7 24.0 92.0 ± 6.9 18.4 
S. cerevisiae 08 23.2 ± 2.8 46.4 58.9 ± 2.1 58.9 187.0 ± 18.2 37.4 
Cells (107 CFU ml-1) were suspended in PBS in the presence of AFB1 at the indicated concentration and 
incubated as described in Table 1. AFB1 analysis by HPLC was performed according to Trucksess et al. 
(1994). Data are means ± standard deviations from three experiments in duplicate. 
Table 2. Aflatoxin B1 remotion by Saccharomyces cerevisiae strains at three different mycotoxin 
concentrations 
 
Strains 
AFB1 concentration (ng ml-1) 
50 100 500 
AFB1 binding 
(ng ml-1) % (ng ml-1) % (ng ml-1) % 
Lactobacillus casei 
subsp. rhamnosus 
18.0 ± 3.4 36.0 56.3 ± 5.4 56.3 338.0 ± 7.2 67.6 
L. rhamnosus I 35.8 ± 1.3 71.6 61.8 ± 3.1 61.8 254.7 ± 4.2 50.9 
L. fermentum 23 22.3 ± 1.2 44.6 41.0 ± 2.8 41.0 225.3 ± 10.8 45.1 
L. acidophilus 24 26.3 ± 1.9 52.6 82.5 ± 3.2 82.5 254.0 ± 25.9 50.8 
L. casei 1 13.8 ± 0.9 27.6 27.5 ± 1.3 27.5 59.0 ± 1.7 11.8 
Cells (5 x 108 CFU ml-1). AFB1 binding to cells was performed as described in Table 2. Data are means ± 
standard deviations from three experiments in duplicate. 
Table 3. Aflatoxin B1 remotion by lactic acid bacteria strains at three different mycotoxin 
concentrations 
Therefore, as AFB1 concentration is highly variable in foods and feeds, the methods of 
selection using a unique aflatoxin B1 concentration may lead to erroneous results. Another 
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very important condition to consider is how to quantify the concentration of employed 
microorganisms, CFU ml-1 or total cells ml-1, where to evaluate whether viable and 
nonviable cells remove AFB1 with the same efficiency becomes necessary.  
Thus, the solution to these problems will be to know the mechanism involved in cell-
aflatoxin interaction, and probably will also allow us to find the microorganism able to 
protect against aflatoxicosis in a wide range of mycotoxin concentration. In this sense, one of 
the objectives of the present study was to develop a theoretical model able to explain the 
binding of AFB1 by LAB and Saccharomyces cerevisiae strains. With this purpose we studied 
as influences on the process involved the following conditions: microorganism-AFB1 time 
contact, aflatoxin B1 and microorganism concentration, cell viability, release of AFB1 bound 
by cells and importance of the microorganism cell wall. 
2.1.1 Microorganism-AFB1 time contact 
Table 4 summarizes some representative results (three LAB and three yeast strains) of the 
studies done in our laboratory when contact time between AFB1 and the microorganisms 
were tested. By varying the incubation time, no significant difference in the amount of 
AFB1 removed for LAB and yeast strains were observed. Furthermore, the process was 
fast, since in 1 minute the microorganism was able to bind the same amount of mycotoxin 
as in 6 h. 
 
Time 
(min)
AFB1 Binding 
(ng ml-1) 
S. cerevisiae 
08 
S. cerevisiae 
RC016 
S. cerevisiae 
CECT 1891 
L. fermentum  
subsp.  
cellobiosus 408 
L. casei 1
L. acidophilus 
P22 
1 182.8 ± 18.2 318.5 ± 5.2 258.0 ± 14.2 61.5 ± 4.3 57.5 ± 2.2 89.4 ± 4.2 
5 194.0 ± 12.6 312.8 ± 6.7 245.5 ± 10.3 64.3 ± 5.1 54.3 ± 3.1 91.8 ± 3.3 
60 178.9 ± 15.7 332.0 ± 10.2 252.7 ± 15.6 62.8 ± 4.6 59.0 ± 4.2 88.9 ± 5.1 
360 193.2 ± 14.6 326.6 ± 12.1 267.2 ± 12.6 63.8 ± 3.5 56.8 ± 2.9 92.3 ± 4.7 
Table 4. Effect of incubation time on aflatoxin B1 binding by viable cells of yeasts and LAB 
AFB1 concentration: 0.5 µg ml-1. Cells number:  yeasts 1 x 107 CFU ml-1; LAB 5 x 108 CFU 
ml-1. AFB1 binding was performed as described in Table 1, except that the incubation time 
varied as indicated in column 1. Data are means ± standard deviations from three 
experiments in duplicate. There is not significant differences (P<0.05) in the means  
values of each column. 
These results are in agreement with other authors (El-Nezami et al., 1998; Peltonen et al., 
2001) who have found no significant differences in AFB1 removal by E. coli, Propionibacterium 
and several LAB strains after 72 h of incubation with the toxin. As for yeast, our results are 
consistent with those reported by Shetty et al. (2007), who have not observed differences 
between 0.5 and 12 h of time contact.  
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If the process needs so little time (one minute), it could suggest that neither the entrance of 
AFB1 into cell nor its metabolic conversion is necessary, therefore microorganism cell wall 
components may be involved in aflatoxin B1 remotion, as was suggested by various authors 
(Haskard et al., 2001; Karaman et al., 2005; Lahtinen et al., 2004; Raju & Devegowda, 2000).  
2.1.2 Mycotoxin and microorganisms concentration  
Effects of different AFB1 concentration on toxin removal by LAB and yeast strains are shown 
in figure 1. Regardless of the studied strain, mycotoxin binding was dependent of its solution 
concentration and was always lineal at low values of AFB1 and showed the transition to a 
plateau with higher toxin concentrations. The amount of toxin removed increased with 
increasing AFB1 concentration, but the percentage removed decreased with increasing toxin 
concentration, because the saturation started. This behaviour strongly suggests that the 
microorganisms have a limited number of sites to bind AFB1 either as free or occupied sites. 
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Fig. 1. (A) Adsorption isotherms of AFB1 by Lactobacillus acidophilus 24 ( ) and Saccharomyces 
cerevisiae 01 ( ). Aliquots of 1 ml of cells (3 x 108 CFU ml-1) for L. acidophilus 24 and (1 x 107 
CFU ml-1) for S. cerevisiae 01, were suspended in PBS in the presence of AFB1 at the following 
concentrations: 2.5; 5.0; 7.5; 10.0; 15.0 and 20.0 µg ml-1. AFB1 binding to cells was performed 
as described in Table 1. (B) AFB1 binding expressed as a percentage of the amount of 
mycotoxin present in the medium. Data are means from triplicate experiments.  
Lee et al. (2003) refer to AFB1 binding as a process of very high-affinity, linear relation with 
the toxin concentration used, and therefore, the amount of AFB1 bound should be 
“limitless”; in other words they conclude that the bacterial surface does not have a defined 
number of binding sites. Our results do not support this idea. An important difference could 
be the number of microorganisms used in the experiments (1010 for Lee et al. and 108 for us), 
including more than a hundred times higher than ours for similar concentrations of AFB1, so 
that the saturation phenomenon could not be observed. 
When a growing number of microorganisms were suspended in PBS in the presence of a 
fixed AFB1 concentration, we observed that the increase in bacterial or yeast concentration 
also reported an increase in AFB1 binding, but it was never sufficient to bind all toxins 
present in the medium. Figure 2 shows the results with Lactobacillus casei subsp. rhamnosus 
which are similar to those obtained with all LAB and yeast strains we analysed.  
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Other authors, including El-Nezami et al. (1998), have also reported that removal of the 
toxin is cell number dependent and the bacterial increase was never sufficient to bind more 
than 90% of the toxin present in the environment. These results suggest that the process 
reached equilibrium between bound toxins (occupied sites) and unbound toxins (free sites) 
and therefore a reversible process could be involved in AFB1 decontamination. 
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Cells, at the concentration indicated, were suspended in PBS in the presence of AFB1 at a concentration 
of 750 ng ml-1 and incubated for 30 min at 37°C. AFB1 binding to cells was performed as described in 
Table 2. Data are means ± standard deviations for triplicate samples.  
Fig. 2. Effect of bacterial concentration on AFB1 removal by Lactobacillus casei subsp. rhamnous 
2.1.3 Cell viability 
To further study the mechanism involved in AFB1 removing, we examined whether cell 
viability affects the AFB1 binding. Results in Table 5 did not show significant differences in 
remotion of the toxin by viable and nonviable cells (obtained by heat treatment).  
Our results are similar to those obtained by El-Nezami et al. (1998) and some of the tested 
strains by Haskard et al. (2001), but different from other authors as Lee et al. (2003) and 
Shetty et al. (2007) who reported that heat treatment of cells enhanced their binding 
abilities among 20-50%. However, this effect was not observed in our study with none of 
the microorganisms tested (seven LAB and nine yeast strains, nine of them including in 
table 5). Therefore, the fact that non viable and viable microorganisms are able to 
eliminate AFB1 with similar efficiency, suggests that the process involved does not require 
metabolic conversion of the toxin by cells and on the other hand, that the total 
microorganism number (cells ml-1) should be employed in the estimation of cellular 
concentration, instead of CFU ml-1. Additionally, these results are indicating that the 
inclusion of viable or nonviable microorganisms in the diet of animals would be equally 
effective against aflatoxicosis. This is very important because the possibility of using 
nonviable cells decreases the risks of their inclusion in the diet. Although the studies to 
ensure that these microorganisms are innocuous for animal health are not easy they 
become highly necessary. 
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Strains 
AFB1 binding 
(ng ml-1) 
Viable Nonviable 
L. fermentum 23 41.8 ± 3.6 45.0 ± 1.1 
L. acidophilus 24 83.4 ± 3.5 78.7 ± 2.9 
L. casei subsp. rhamnosus 54.7 ± 6.5 56.3 ± 10.5 
L. rhamnosus I 61.8 ± 3.1 63.0 ± 2.1 
L. paracasei subsp. paracasei 72.4 ± 5.5 69.5 ± 4.5 
L. casei 1 27.5 ± 3.8 23.5 ± 1.1 
S. cerevisiae CECT 1891 55.2 ± 7.5 53.0 ± 5.4 
S. cerevisiae 08 58.9 ± 2.1 55.8 ± 2.3 
S. cerevisiae RC016 49.1 ± 1.4 52.4 ± 1.7 
Cells (107-108 cell ml-1) were suspended in PBS in the presence of AFB1 at a concentration of 100 ng ml-1 
and incubated for 30 min at 37°C. AFB1 binding to cells was performed as described in Table 2.  Non 
viable cells were obtained by heat treatment (autoclaving for 20 min at 121°C) from the same sample of 
viable cells. Data are means ± standard deviations from three experiments in duplicate. There is not 
significant differences (P<0.05) in the means values of each row. 
Table 5. Aflatoxin B1 binding upon exposure to viable and nonviable cells  
2.1.4 Aflatoxin B1 released  
The stability of the complex aflatoxin B1-microorganism was studied by the application of 
repeated washings with PBS buffer (aqueous solvent) or acetonitrile (organic solvent in 
which AFB1 is very soluble) of the cellular pellets that previously bound the mycotoxin, 
additionally the effect of the variation in the washing time was included.  
Table 6 shows some representative results from all LAB and a yeast strains assayed in  
our laboratory. After five washings with PBS or acetonitrile, the AFB1 released was ≥ 90% 
for the organic solvent treatment and close to 50% for the PBS treatment; on the other hand, 
the washing time did not change the release percentages when it varied from 1 to 60 
minutes. 
These results suggest that the process involved is fast and reversible. Moreover they confirm 
that metabolic conversion of the toxin by cells did not take place, because the aflatoxin B1 
was released in the same chemical form from microorganisms.     
Reversibility of the process has previously been reported by other authors, for example, 
twelve LAB strains in both viable and non viable forms, tested by Haskard et al. (2001) 
exhibited reversible binding of AFB1 after five washings too. Moreover, they also noted that 
the release of bound toxin was dependent on the washing solution employed, because only 
6% to 11% of the bound AFB1 was released using water, but when the complex was 
suspended in methanol, acetonitrile, chloroform, or benzene 83% to 99% of the bound AFB1 
was released. Similar findings have been reported by Peltonen et al. (2001) and Hernandez-
Mendoza et al. (2009), the latter authors showed that employing PBS around 20-30% of AFB1 
bound was released and suggested that the aflatoxin B1 is attached to the bacteria by weak, 
non covalent interactions that could be at least partially reversible. 
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Time
(min)
AFB1 released (%)
PBS Acetonitrile
L. acidophilus
P22
L. fermentum
subsp. 
cellobiosus
408
L. casei 1
S. cerevisiae
CECT 1891
L. acidophilus
P22
L. fermentum
subsp. 
cellobiosus
408
L. casei 1
S. cerevisiae
CECT 1891
1 57.9 ±7.0 50.4 ± 3.5 42.3 ± 1.8 40.8 ± 2.1 98.3 ± 9.8 95.7 ± 5.6 94.4 ± 4.3 90.6 ± 4.1
10 58.7 ± 8.8 51.9 ± 2.7 43.8 ± 2.1 39.7 ± 1.2 97.0 ± 4.5 89.6 ± 8.9 91.8 ± 4.8 92.4 ± 3.9
60 61.0 ± 3.5 53.8 ± 3.9 44.1 ± 3.4 41.2 ± 1.5 98.4 ± 5.9 95.4 ± 5.8 95.9 ± 4.8 94.1 ± 4.2
 
For the aflatoxin release assay, cells (107-108 cells ml-1) were incubated with AFB1 at a concentration of 
0.5 µg ml-1 for 30 min at 37°C and then centrifuged. Pelleted cells with bound AFB1 were suspended in 1 
ml of PBS or acetonitrile and incubated at the indicated times at 37°C with shaking. After that the 
microorganisms were pelleted by centrifugation, the supernatant containing the released AFB1 was 
collected by HPLC analysis as was performed in Table 2. This process was repeated five times. The 
AFB1 released (total from five washing) was expressed as a percentage of the total AFB1 bound. Data are 
means ± standard deviations from triplicate experiments.  
Table 6. Effects of different solvents and washing time on AFB1 released by  
microorganisms  
2.1.5 Importance of the microorganism cell wall 
Although bibliographic data suggest that structural components of the cell wall of yeasts 
and LAB, are responsible in AFB1-microorganism interaction (Karaman et al., 2005; Lahtinen 
et al., 2004), we designed an experiment to evaluate if yeast without cell wall (spheroplasts) 
are able to remove AFB1, in order to confirm this assertion. 
 
 AFB1 binding 
Sample* 0.25 µg ml-1# 2.5  µg ml-1# 
 (µg ml-1) (%) (µg ml-1)  (%) 
Cells control 0.14 ± 0.01a 56.0 1.25 ± 0.10a  50.0 
Spheroplasts 0.02  ± 0.01b 8.0 0.05 ± 0.01b  2.0 
Supernatant of spheroplasts 0.02 ± 0.00b 8.0 0.08 ± 0.01c  3.2 
*Cells and spheroplasts: 107 ml-1. #AFB1 concentration in liquid media. The samples were suspended in 1 
ml PBS in the presence of AFB1 at a concentration of 0.25 µg ml-1 or 2.5 µg ml-1 and incubated for 30 min 
at 37°C. AFB1 binding was performed as described in Table 2. Data are means ± standard deviations 
from triplicate experiments. Means with different letters in the same column differ significantly 
(P<0.05). 
Table 7. Aflatoxin B1 binding by cells, spheroplasts and supernantant of spheroplasts of 
Saccharomyces cerevisiae CECT 1891 
The spheroplasts were obtained by the treatment with Zymolyase containing a protease 
activity with affinity for mannoproteins, and a β1,3 glucanase activity. The actions of both 
enzymatic activities were required to lyses yeast cell wall (Ovalle et al., 1998) and allowed us 
to obtain spheroplasts and the released products of the enzymatic breakdown, separately. 
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Thus, to determine the AFB1 binding with three different samples: i) whole cells of  
S. cerevisiae CECT 1891 (cells control), ii) spheroplasts from cell control and iii) a concentrate 
of the supernatant from spheroplasts corresponding to 107 cells, was possible.  
As Table 7 shows, neither spheroplasts nor its supernatant were able to remove AFB1 from 
liquid medium, since very low uptake rates not even changed when the concentration of 
aflatoxin B1 in the medium was increased 10 times, suggesting that these binds were 
nonspecific.   
These results confirm that the compounds involved in AFB1 binding to yeast, are 
components of the cell wall and that it must keep its structure in order to remove AFB1 
effectively. Similar results were reported by Hernandez-Mendoza et al. (2009), who 
demonstrated that the data obtained in binding assays with bacterial cell wall indicated that 
these purified fragments effectively bind AFB1 as reported previously by Lahtinen et al. 
(2004). Furthermore, loss of the bacterial cell wall in response to treatments with enzymes 
showed a reduction in AFB1 binding capacity relative to that of whole cells. These results 
demonstrate the importance of cell wall integrity in binding AFB1 by LAB strains, and 
confirm the role of a cell wall-related physical phenomenon as opposed to a metabolic 
degradation reaction. 
2.1.6 Mechanism proposed for the interaction between Aflatoxin B1 with yeast and 
lactic acid bacteria strains 
According to an integrated synthesis of the results reported above, it is clear that: (i) the 
removal and release of toxins is a fast and reversible process, (ii) this process does not 
involve AFB1 chemical modification, (iii) the amount of AFB1 removed is toxin- and cell 
concentration-dependent, (iv) the same result is obtained with viable and nonviable (heat-
treated) cells and (v) the cell wall of the microorganism integrity is necessary for the 
"binding" mechanism between AFB1 and the cells. Briefly, the process involved is, by nature, 
reversible and fast kinetic. Accordingly, this process can be analyzed as a PHISICAL 
ADSORPTION (physisorption), and probably the binding forces involved are a weak Van 
der Waals type, hydrogen bonds, or hydrophobic interaction.  
Following this an adsorption phenomenon to the external microorganism surface to explain 
AFB1 binding is proposed (Figure 3). This model considers the attachment of AFB1 
molecules to the microorganism surface. The relationship between the amounts of the AFB1 
at the microorganism surface as a function of its solution concentration is described by an 
adsorption isotherm. The shape of the isotherm shows linearity at low values of AFB1 and 
then shows the transition to a plateau (Figure 4A). This type of isotherm can be described by 
the following equation:  
Adsorption = M [AFB1]eq x Keq / 1 + [AFB1]eq Keq (Figure 3) 
where M is the maximum number of adsorption sites per microorganism, and Keq 
(expressed in liters per mole) is equivalent to the affinity (or cohesion force) of AFB1 
molecules for the adsorption sites. The linearized form of the isotherm is the double-
reciprocal plot from the saturation curve (1/adsorption = 1/[AFB1]eq 1/M Keq + 1/M), as 
shown in Figure 4B. From the slope and interception of the resulting line, factors M and Keq 
can be determined. The most efficient microorganism would be that having maximal M and 
Keq values. Note that this physisorption model does not discriminate between viable and 
nonviable cells, i.e., cell concentrations should be determined by a hemocytometer instead of 
CFU per milliliter. 
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AFB1 + S               S-AFB1
[S-AFB1] Xso
Keq =                                  =                     
[AFB1]  [S] [AFB1]  Xsf
Xso + Xsf = 1 and Ø = Xso
Xsf =  1  – Ø           and       Keq =  Ø  /   [AFB1]  (1 – Ø)
Ø  =  [AFB1] Keq /  1 + [AFB1] Keq
M [AFB1] Keq
Adsorption  =   M  x  Ø                 and                    Adsorption   = 
1 +  [AFB1] Keq
1 / adsorption  =  1 / [AFB1]eq 1 / M Keq +  1 / M  
Fig. 3. Theoretical model proposed to explain the adsorption process of AFB1 by LAB and S. 
cerevisiae. The equations permit the calculation of the total binding sites per microorganism 
(M) and the equilibrium constant (Keq) involved in the process. Sf is the amount of free sites 
in the surface cellular. So represents the occupied sites in the cell surface and is equivalent to 
S-AFB1, determined as the AFB1 bound to the cell. [AFB1] is the AFB1 concentration in the 
equilibrium condition of the system, determined as the free AFB1 in the medium. Xso (Ø) is 
the molar fraction of occupied sites (mol So/mol total). Xsf (1 - Ø) is the molar fraction of 
free sites (mol Sf/mol total). Adsorption is the amount of molecules of AFB1 bound per cell 
(M x Ø). 
Figure 4A shows the saturation curve of L. acidophilus Po22 and L. fermentum subsp. 
cellobiosus 408 when the process is considered physisorption and indicates that the two 
strains have similar AFB1 binding efficiency per bacterium, particularly for low 
concentrations of toxin. This result is different from the ones reported in Table 1 based only 
on viable bacteria (CFU ml-1) and assayed with a unique mycotoxin concentration, since L. 
acidophilus Po22 was more efficient in AFB1 binding (42.8%) than L. fermentum subsp. 
cellobiosus 408 (13.2%). However, we determined that in these assays Po22 strain had more 
dead cells than 408 strain, consequently Po22 had more total cells and showed higher 
percentage of AFB1 binding. In terms of our proposed adsorption model, L. fermentum 
subsp. cellobiosus 408 has lower M values but higher Keq values than L. acidophilus Po22 (Table 
8), and these two factors balance to give toxin adsorption efficiencies of 9.37 and 6.25 x 1010 
respectively. 
According to adsorption model, a larger cell surface is associated with higher total sites per 
cell (M). To test this possibility, we measured AFB1 adsorption in three yeast strains and the 
saturation curves are shown in Figure 5. 
The adsorption of AFB1 by S. cerevisiae RC016 (from pig gut), S. cerevisiae RC008 (from 
feed stuff) and S. cerevisiae CECT 1891 (from culture collection) was dependent on the 
toxin concentration in the medium, which is similar to the results showed in Figure 1 by  
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S. cerevisiae 01 and L. acidophilus 24. The data from Figure 5 were employed to construct 
the respective adsorption isotherms to obtain the M and Keq values for these systems, and 
they are shown in Table 8. The M values were 25- to 1,000-fold higher for the yeast strains 
than for the bacteria, whereas Keq values were similar, as differences never exceeded  
3 times. Thus, the yeast strains respect to bacterial strains, showed a ~50-300-fold higher 
efficiency to AFB1 removal from the medium, mainly for their high M values. 
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Fig. 4. Adsorption isotherms of AFB1 by L. fermentum 408 ( ) and L. acidophilus Po22 ( ). 
Aliquots of 1 ml of cells (0.89 x 109 cells for L. fermentum 408; 1.20 x 109 cells for  
L. acidophilus Po22) were suspended in PBS in the presence of AFB1 at the following 
concentrations: 0.5; 1.0; 2.5; 5.0 and 10.0 µg ml-1. Then, the bacteria were incubated for  
30 min at 37°C and pelleted by centrifugation. The supernatant was collected for free 
AFB1 analysis by HPLC according to Bueno et al. (2007). AFB1 bound to cells was 
calculated as the difference between the total AFB1 and the amount of free AFB1. The 
adsorption was calculated as the ratio between the molecules of AFB1 bound to cells  
and the amount of cells in the incubation medium. The [AFB1]eq was equivalent to the  
free AFB1. (A) Saturation curve. (B) Inverse plot of the same data as (A). Data are means  
from triplicate experiments. 
Lee et al. (2003) described an adsorption process by three different bacteria strains, in viable 
and nonviable forms, as a function of AFB1 concentration. For comparative purposes, we 
applied our theoretical model to the data of Lee et al. (Table 8, lines 3 through 5), and the M 
and Keq values for their three LAB strains were calculated. L. rhamnosus LC- 705 had the 
most efficient AFB1 removal. However, all three strains were less efficient than P22 and 408, 
mainly because they had smaller M values. Strain LGG-V of Lee et al. was 10-fold less 
efficient than 408, since its M value was 10-fold smaller as well (Table 8). 
We proposed a theoretical model of adsorption applicable to microorganisms that bind 
AFB1 and this model allows an estimation of the number of aflatoxin B1 binding sites per 
microorganism (M), the system equilibrium constant (Keq), and the efficiency of cells to 
remove AFB1 from liquid medium (M x Keq). We analyzed three systems: two Lactobacillus 
strains (L. acidophilus Po22 and L. fermentum subsp. cellobiosus 408) no tested before, three  
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Cells, at the concentration indicated, were suspended in 1 ml of PBS with different AFB1 concentrations 
(1; 5; 10; 15; 20 µg ml-1) and incubated for 30 min at 37°C. AFB1 binding to cells was performed as 
described in Fig. 1. Data are means ± standard deviations for triplicate samples. 
Fig. 5. AFB1 binding upon exposure to S. cerevisiae CECT 1891 (1 x 107 cells ml-1) ( ), S. 
cerevisiae  RC008 (4.8 x 107 cells ml-1) ( ), S. cerevisiae RC016 (2.5 x 107 cells ml-1) ( ).   
 
Strains 
M
(1x106 sites cell-1)
Keq 
(1x104 M-1) 
Efficiency 
(1x1010) 
L. acidophilus Po22 8.33 0.75 6.25 
L. fermentum subsp. cellobiosus 408 6.25 1.50 9.37 
LC705-NV 1.48 3.12 4.62 
PJS-NV 1.00 2.80 2.80 
LGG-V 0.64 1.40 0.89 
S. cerevisiae RC016 580.00 0.80 460.00 
S. cerevisiae RC008 200.00 2.20 440.00 
S. cerevisiae CECT 1891 1,000.00 3.12 3,120.00 
Table 8. Total binding sites per microorganism (M), equilibrium constant (Keq) and efficiency 
(M x Keq) for different strains. M, Keq and M x Keq for various microorganisms were 
calculated by linear regression by the following equation: 1/adsorption = (1/[AFB1]) x 1/M 
x Keq + 1/M, as described in Fig. 3. The data for linear regression construction were extracted 
from Fig. 4A for L. acidophilus Po22 and L. fermentum subsp. cellobiosus 408 strains, from Fig. 5 
for S. cerevisiae strains and from Fig. 1 from Lee et al. (2003) for LC705-NV (Lactobacillus 
rhamnosus strain, nonviable cells), PJS-NV (Propionibacterium freudenreichii subsp. Shermanii 
JS, nonviable cells), and LGG-V (L. rhamnosus GG, viable cells).  
yeast strains (S. cerevisiae RC016, S. cerevisiae RC008 and S. cerevisiae CECT 1891) no studied 
before either, and LAB studied by another laboratory (Lee et al. 2003). The most efficient 
microorganism was S. cerevisiae CECT 1891, mainly because binds more AFB1 per cell (Table 
8). As we mentioned before, in AFB1 binding to the yeast, the main components involved are 
cell wall glucomannans (Karaman et al., 2005), whereas cell wall peptidoglycans are 
responsible for AFB1 removal by LAB (Lahtinen et al., 2004). Unexpectedly, bacteria and 
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yeast had a Keq value within the same order of magnitude, varying from 0.75 to 3.12 x 104  
M-1; in addition, S. cerevisiae CECT 1891 and LC705-NV had the same Keq (Table 8). High 
efficiency resulted from high M value rather than from any variation in the Keq value. These 
observations suggest that binding efficiency is a more quantitative phenomenon (large 
surface area) than a qualitative phenomenon (chemical structure involved in the 
interaction), and in this sense the analysis of the glucomannan and peptidoglycan chemical 
structures did not indicate major differences in the capacity to produce hydrophobic 
interactions or hydrogen bonds, which are presumably involved in the binding. The main 
application of the proposed model is its usefulness for the selection of the most efficient 
microorganism to remove AFB1. Sacharomyces cerevisiae CECT 1891 was clearly the most 
efficient microorganism in the present study because it had high values of M and Keq. When 
the election is between microorganisms with similar efficiencies (M x Keq)—for example, L. 
acidophilus P22 and LC705-NV or S. cerevisiae RC016 and S. cerevisiae RC008 (see Table 8)—the 
model suggests that the election should be the cell with the high Keq factor (LC705- NV and 
S. cerevisiae RC008, respectively). In fact, when a microorganism-AFB1 complex is exposed to 
consecutive washings, for example during gastrointestinal transit, the microorganism with 
the high value of Keq will release few toxins. This is consistent with the results of Lee et al. 
(2003), who determined the constants of AFB1 release for LC705-NV, PJS-NV, and LGG-V, 
which showed an inverse correlation with the respective Keq values calculated by us (Table 
8) and therefore the greatest constant of release of minor Keq factors. Our results for L. 
acidophilus P22 and S. cerevisiae CECT 1891 also show the same correlation, i.e., that L. 
acidophilus P22 has a greater constant of release of minor Keq factors than S. cerevisiae CECT 
1891 (Table 8) and releases a greater percentage of AFB1 than yeast strain does, when both 
are exposed to washings (Table 6). Therefore, it is clear that the microorganism with the 
greater Keq factor has less toxin releases and this fact will be very important during passage 
through the gastrointestinal tract, where mainly aflatoxins are absorbed (Gratz et al., 2004). 
When we analyzed the effect of mycotoxin and microorganism concentration, we remark 
the differences with the results obtained by Lee et al. (2003) who did not report saturability 
during the AFB1 binding process, and we suggest that the high cell concentration employed 
by these authors was responsible of this non-saturation. For the same reason, our 
experiments with yeast strains were made with concentrations of 107 cells per ml, 100 times 
less than for bacteria; otherwise, the saturation was hidden.  
Another important use of this adsorption model is its capacity to explain probable changes 
in the adsorption efficiency of the microorganisms (M x Keq) after physical, chemical, or 
genetic treatments on the microorganisms. In fact, we can determine whether such changes 
are induced by modifications of M, Keq, or both. This knowledge will help us to select the 
most efficient microorganisms for protection against AFB1.  
Although the results described come from in vitro experiments, some preliminary experiments 
in our laboratory (data not shown) suggest that the addition of S. cerevisiae CECT 1891 to 
poultry diet would help to prevent acute aflatoxicosis, chronic aflatoxicosis, or both.  
In summary, when experiments in vitro made with a definite microorganism concentration 
and variable AFB1 concentration show saturability, the adsorption model will be applicable 
and will allow a determination of M and Keq values, both of which are useful when selecting 
the most efficient microorganism to remove AFB1 in a wide range of mycotoxin concentration. 
2.2 Evaluation of the gastrointestinal tolerance and anti-pathogenic bacterial 
influence of Saccharomyces cerevisiae strains  
An interesting alternative to protect against aflatoxicosis, after the selection of the most 
efficient microorganism in AFB1 remotion is to research its potential beneficial properties on 
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the host. While our proposed model above includes the possibility of using dead 
microorganisms and with the same aflatoxin B1 binding efficiency, the inclusion in the diet 
of viable cells would add other beneficial effects to the animal we want to protect.  
So, if the aim is to use living microorganisms, the first study to perform is to evaluate their 
tolerance to the gastrointestinal conditions, because acid in the stomach and bile salts in the gut 
are the first biological barriers to be overcome after ingestion (Gueimonde & Salminen, 2006). 
In recent years, much attention has been paid to the design of functional foods that contain 
probiotic microbial strains responsible for health benefits in the host (Kumura et al., 2004). 
Several authors have demonstrated the safety of Saccharomyces cerevisiae for nutritional and 
pharmaceutical use in animal feed in the European Economic Community and in Japan 
(Nitta & Kobayashi, 1999). Moreover, the Food and Drug Administration has given level of 
insurance or GRAS (generally regarded as safe) microorganism degree to Saccharomyces 
cerevisiae strains (http://www.fda.gov/Food/FoodIngredientsPackaging/ucm078956.htm). 
Microorganisms capable of withstanding the gastrointestinal transit (≥70% survival), have 
drawn attention to their possible use as probiotics (Lourens-Hattingh & Viljoen, 2001), and 
in this sense these microorganisms will be considered for further studies in order to evaluate 
their potential beneficial properties. 
We employed this strategy to study four Saccharomyces cerevisiae strains isolated from pig 
environment, previously analyzed for their AFB1 binding ability (Table 1 and 2), including 
assays for: i) gastrointestinal tolerance, ii) auto-aggregation, iii) cellular adhesion, iv) co-
aggregation and v) antagonism to pig pathogens (Armando et al., 2011) 
2.2.1 Selection of Saccharomyces cerevisiae strains for their tolerance to 
gastrointestinal conditions 
The effect of simulated GI transit on viability of S. cerevisiae strains is presented in Table 9. 
All the yeast strains were able to survive under gastrointestinal conditions. In general, the 
strains retained viability through salivary (M2) conditions. Saccharomyces cerevisiae RC009 
strain showed an increase in viability during transit to gastric (M3) and intestinal (M4) 
conditions; whereas S. cerevisiae RC008 strain did not increase the cell density but 
maintained the number of viable cells throughout the gastrointestinal transit. Saccharomyces 
cerevisiae RC012 showed a small decrease in viability after passage intestinal conditions 
(M4). In contrast, the RC016 strain was able to grow at these conditions. 
 
Source 
S. cerevisiae
Strains 
Viable count (log10 CFU ml-1) during simulated GI transit tolerance 
M1 M2 M3 M4 
Feedstuff RC008 6.4 ± 0.40 a 6.7 ± 0.17 a 6.5 ± 0.06 a 6.8 ± 0.11 a 
Feedstuff RC009 6.7 ± 0.23 b 6.4 ± 0.11 b 7.2 ± 0.17 a 7.5 ± 0.21 a 
Feedstuff RC012 6.4 ± 0.26 b 6.9 ± 0.15 b 6.4 ± 0.21 b 6.1 ± 0.26 c 
Pig gut RC016 7.3 ± 0.17 a 7.1 ± 0.15 b 5.8 ± 0.17 c 7.5 ± 0.06 a 
Results are shown as mean ± SD (standard deviation). M1: cell counts prior to assaying the GI transit 
tolerance. M2: salivary conditions tolerance assay. M3: gastric conditions tolerance assay. M4: intestinal 
conditions tolerance assay. Values with the same letter are not significantly different according to 
Fisher’s protected LSD test (p<0.0001). Statistical analysis compared means obtained from each yeast 
strain separately.  
Table 9. Effect of simulated gastrointestinal (GI) transit on viability of Saccharomyces 
cerevisiae strains 
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The ability to survive gastrointestinal simulated conditions is an absolute need of probiotic 
microorganisms, and it is generally included among the criteria used to select potential 
probiotic strains (Morelli, 2000). In this work, all the assayed strains were able not only to 
resist gastrointestinal passage but also to grow under these conditions. Other authors have 
reported the same results with S. cerevisiae strains isolated from infant faeces and feta cheese 
(Psomas et al., 2001) and with S. cerevisiae var boulardii strain isolated from food (van der Aa 
Kuhle et al., 2005). However, the use of bacteria has demonstrated a very low recovery after 
being subjected to these gastrointestinal in vitro conditions (Gusils et al., 2002). Lin et al. 
(2007) reported a 2 or 3 log decrease in Lactobacillus fermentum strains isolated from swine 
and poultry. In agreement with our results, Pennacchia et al. (2008) reported that more than 
50% of S. cerevisiae strains exposed to simulated passage through the human GI tract, 
showed 70% survival. 
2.2.2 Auto-aggregation assay 
Table 10 shows the auto-aggregation ability of the tested S. cerevisiae strains. Results showed 
that RC008, RC009 and RC016 strains exhibited a strong auto-aggregation score while RC012 
strain exhibited weak auto-aggregation. This ability, or formation of multicellular clumps 
between microorganisms of the same strain, is a measure of the adhesion ability to epithelial 
cells and could be related to biofilm formation. The percentages of auto-aggregation 
obtained ranged from 85.3 to 97.9%, indicating that all strains showed an auto-aggregative 
phenotype. 
 
S. cerevisiae 
Strains 
OD600 (t0)1 OD600 (t1)2 [1- (OD600 t1 / OD600 t0)] x 100 % 
Aggregation 
Score3 
RC008 1.144 0.088 92.3 ++ 
RC009 1.173 0.025 97.9 ++ 
RC012 0.974 0.144 85.3 + 
RC016 1.099 0.079 92.9 ++ 
1Cells were harvested by centrifugation and suspended in PBS to optical density ~1 (O.D.) units at  
600 nm. 2Optical density of the upper suspension (O.D.) units at 600 nm after incubation at 37ºC for 2 h.   
3 (++) strong; (+) weak; (-) negative 
Table 10. Auto-aggregation ability of Saccharomyces cerevisiae strains 
2.2.3 Adhesion assay 
The number of yeast cells adhesive to 100 Vero cells at different inoculums sizes of S. 
cerevisiae is shown in Table 11.  
Results indicate that the adhesion ability of yeasts varied among strains according to the 
density of yeast cells. At 106 cells ml-1 the strains showed different adhesion ability: some of 
them had high adhesion capability while in others it was low. At 107 cells ml-1 all strains 
showed a similar strong adhesive ability to Vero cells. Adhesion ability of probiotcs to 
intestinal mucus and to enterocytes is an important prerequisite for transient colonization of 
the host intestinal tract. Adhesion to the mucosa is also considered to be an important factor 
for modulation of the immune system and for antagonistic activity against enteropathogens 
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(Ouwehand et al., 2002). Some authors reported a strong relationship between auto-
aggregation and adhesiveness (Del Re et al., 2000), in line with the results obtained by us. 
 
S. cerevisiae 
Strains 
Cells ml-1 
Yeast cell number / 100 Vero cells 
Mean ± SD1 LSD test2 
RC008 
106 18.5 ± 0.16 g 
107 154.0 ± 0.09 b 
RC009 
106 107.3 ± 0.09 d 
107 178.2 ± 0.02 a 
RC012 
106 109.5 ± 0.13 c 
107 154.8 ± 0.26 b 
RC016 
106 48.9 ± 0.04 f 
107 105.9 ± 0.15 e 
Twenty randomized microscopic fields per coverslip were counted. Each adhesion assay was conducted 
in duplicate with cells from three successive passages. Adhesion was expressed as a mean of yeast 
adhering per 100 Vero cells. Controls without S. cerevisiae strains were included. 1Mean ± Standard 
Deviation (SD). 2Values corresponding to the same letter are not significantly different according to 
Fisher’s protected LSD test (P<0.05).  
Table 11. Adhesion of Saccharomyces cerevisiae strains to Vero cells 
2.2.4 Co-aggregation assay 
Co-aggregation among S. cerevisiae and pathogens is shown in Table 12. The results showed 
that the capacity of yeast to bind to a microorganism varies according to yeast strain and the 
microorganism involved. Some yeast strains varied from non co-aggregation to good co-
aggregation ability when they interact with E. coli, Salmonella sp. or Enterobacter sp.. 
Saccharomyces cerevisiae RC016 strain was able to co-aggregate with all the pathogens tested, 
while the rest of the strains only co-aggregate with one of the pathogenic bacteria. 
 
S. cerevisiae 
Strains 
Co-aggregation score1 
E. coli Enterobacter sp. Salmonella sp. 
RC008 0 2 0 
RC009 0 0 1 
RC012 0 0 1 
RC016 1 1 1 
Yeast suspension (1 x 107 CFU ml-1 in PBS) was mixed with each pathogen strain (1 x 107 CFU ml-1 in 
PBS). Suspension was mixed and incubated for 4 h at 37ºC, under agitation at 200 rpm. Suspensions 
were observed by optic microscopy after Gram staining. 1The score is based upon a scale described by 
Mastromarino et al. (2002), from 0 for no aggregation to 3 for maximum aggregation. 
Table 12. Co-aggregation assay between Saccharomyces cerevisiae and pathogen strains 
Co-aggregation and inhibition of pathogens are some of the most important beneficial 
health claims of probiotics. The co-aggregation ability of probiotic strains might enable 
them to form a barrier that prevents colonization by pathogenic bacteria (Collado et al., 
2007). 
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2.2.5 Antagonism to pig pathogens 
The antibacterial activity of yeast strains towards potential pathogenic bacteria was assayed 
(Table 13). Three of the tested S. cerevisiae were inhibitory against the pathogens studied. 
The RC008 and RC016 strains had the strongest antimicrobial activity; they were able to 
inhibit all the pathogens tested. 
Most yeast strains are able to produce diffusible antimicrobial substances that inhibit the 
growth of pathogens. It was reported that certain S. cerevisiae strains secrete a protein toxin 
that kills not only sensitive strains of the same species but also other yeasts (Kitamoto et al., 
1999). In our study, yeasts were able to inhibit pathogenic bacteria, but the nature of the 
antimicrobial substance is unknown. 
 
S. cerevisiae 
Strains 
Antimicrobial activity1 
Escherichia coli Salmonella enterica Enterobacter cloacae 
RC008 ++ ++ ++ 
RC009 - - - 
RC012 + + + 
RC016 ++ ++ ++ 
1 +: inhibition zone ≥ 3 mm and ≤ 9 mm; 
 ++: inhibition zone ≥ 10 mm and ≤ 15 mm;  
-: inhibition zone ≤ 3 mm. 
A central streak of each yeast strain was performed on Petri dishes containing YPD agar and incubated 
for 48 h at 37°C. Ten millilitres (10 ml) of additional liquid YPD agar were added to each plate and each 
pathogenic strain was streaked (perpendicularly) across the same agar plate. After 24 h incubation, 
antagonistic effect was determined by the appearance of clear zones surrounding the junctions of the 
streak lines.  
Table 13. Saccharomyces cerevisiae antimicrobial activity against pathogen strains 
In summary, the results let us predict that S. cerevisiae RC016 and S. cerevisiae strain RC008 
may be regarded as the most promising beneficial yeast candidate for functional feed 
product development because they both had good and similar AFB1 remotion efficiency 
(Table 8), higher than S. cerevisiae RC009 and S. cerevisiae RC012 (data not shown) and the 
strongest capacity of pathogen inhibition. They were also able to survive under 
gastrointestinal conditions and adhere to intestinal cells. Other functional and technological 
tests should be performed for the validation of these strains as suitable probiotics for 
animals, and future studies should be conducted to evaluate the influence of S. cerevisiae 
strains on non-pathogenic bacteria. But evidently S. cerevisiae RC008 and S. cerevisiae RC016 
are the best candidates, from the four yeast strains analyzed, for further studies in vivo 
designed to prevent aflatoxicosis.  
3. Conclusions 
As we have seen, the potential presence of aflatoxins in animal diet is unavoidable, therefore 
a protection against aflatoxicosis is necessary, and the inclusion in the diet of 
microorganisms able to remove AFB1 is the most suitable alternative. Moreover, if the 
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microorganisms capable to avoid the aflatoxin absorption during its gastrointestinal transit 
have beneficial properties on the host, this way to prevent aflatoxicosis is highly promising.  
With the increasing interest in food safety throughout the world, the yeast and LAB cultures 
with high mycotoxin binding abilities and probiotic abilities are of immense value in 
reducing aflatoxin exposure.   
The first section of this work presents in vitro experiments useful to the development of a 
model that considers the aflatoxin-microorganism interaction as a fast, reversible and strain 
specific process, concluding that it is a physical adsorption to the cell wall of the 
microorganism. The model is a tool for selecting the most efficient microorganism to remove 
AFB1 in a wide range of mycotoxin concentration, since feed AFB1 contamination is variable. 
Another important use of this model is its capacity to explain probable changes in the 
adsorption efficiency (M x Keq) of the microorganism after than physical, chemical or genetic 
treatments designed to obtain the ideal microorganism; i. e. if either the process equilibrium 
constant (Keq) or the number of binding sites for AFB1 in the surface microorganism (M) 
change, or both. 
The application of the adsorption model to yeast and LAB strains showed that Saccharomyces 
cerevisiae CECT 1891 was the most efficient microorganism in AFB1 remotion, but in general 
also showed that the yeasts had higher efficiencies than LAB, mainly because the M values 
were 20- to 1,000- fold higher for the yeasts than for the bacteria, whereas the Keq values 
were similar. 
The second part of this chapter shows the design of simple experiments in vitro to evaluate 
potential beneficial properties of the microorganisms under study, on the host. In this sense, 
the tolerance of gastrointestinal conditions, auto and co-aggregation, cell adhesion and 
antibacterial activity towards pathogenic bacteria, of four yeast strains from pig 
environmental, were assayed. The results showed that Saccharomyces cerevisiae RC016 and 
Saccharomyces cerevisiae RC008 were the best microorganisms, mainly because they showed 
high and similar AFB1 remotion efficiency and the strongest antimicrobial activity against 
pathogen strains.  
Thus, the combination of both strategies allows us to select, among all the microorganisms 
tested (LAB and yeasts), the best candidate for future in vivo studies. This selection is very 
important because, although in vivo studies are necessary, they are expensive, complicated 
and long lasting as well. So, in summary, this research represents an efficient in vitro 
strategy to select the correct microorganisms for future in vivo studies, useful to prevent 
aflatoxicosis in farm animals.  
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